126 related articles for article (PubMed ID: 38056181)
1. Pathogenicity and immunogenicity of a quadruple gene-deleted pseudorabies virus variant as a vaccine candidate.
Ma Z; Jiang C; Liu D; Gao Y; Bai J; Jiang P; Liu X
Vet Microbiol; 2024 Jan; 288():109931. PubMed ID: 38056181
[TBL] [Abstract][Full Text] [Related]
2. Pathogenicity and immunogenicity of a gI/gE/TK/UL13-gene-deleted variant pseudorabies virus strain in swine.
Lv L; Liu X; Jiang C; Wang X; Cao M; Bai J; Jiang P
Vet Microbiol; 2021 Jul; 258():109104. PubMed ID: 34004569
[TBL] [Abstract][Full Text] [Related]
3. Recombinant pseudorabies virus with gI/gE deletion generated by overlapping polymerase chain reaction and homologous recombination technology induces protection against the PRV variant PRV-GD2013.
Li W; Zhuang D; Li H; Zhao M; Zhu E; Xie B; Chen J; Zhao M
BMC Vet Res; 2021 Apr; 17(1):164. PubMed ID: 33853597
[TBL] [Abstract][Full Text] [Related]
4. Comparative pathogenicity and immunogenicity of triple and double gene-deletion pseudorabies virus vaccine candidates.
Dong J; Bai J; Sun T; Gu Z; Wang J; Sun H; Jiang P
Res Vet Sci; 2017 Dec; 115():17-23. PubMed ID: 28130999
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of an attenuated Chinese pseudorabies variant by dual deletion of TK&gE genes.
Wang J; Song Z; Ge A; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Zheng Y; Fan H; Hou J
BMC Vet Res; 2018 Sep; 14(1):287. PubMed ID: 30241529
[TBL] [Abstract][Full Text] [Related]
6. A noval strategy of deletion in PK gene for construction of a vaccine candidate with exellent safety and complete protection efficiency against high virulent Chinese pseudorabies virus variant.
Xu M; Zhang C; Liu Y; Chen S; Zheng Y; Wang Z; Cao R; Wang J
Virus Res; 2022 May; 313():198740. PubMed ID: 35271886
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the protective efficacy between the candidate vaccine ZJ01R carrying gE/gI/TK deletion and three commercial vaccines against an emerging pseudorabies virus variant.
Jiang C; Ma Z; Bai J; Sun Y; Cao M; Wang X; Jiang P; Liu X
Vet Microbiol; 2023 Jan; 276():109623. PubMed ID: 36495739
[TBL] [Abstract][Full Text] [Related]
8. A novel inactivated gE/gI deleted pseudorabies virus (PRV) vaccine completely protects pigs from an emerged variant PRV challenge.
Gu Z; Dong J; Wang J; Hou C; Sun H; Yang W; Bai J; Jiang P
Virus Res; 2015 Jan; 195():57-63. PubMed ID: 25240533
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant in susceptible animals.
Cong X; Lei JL; Xia SL; Wang YM; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
Vet Microbiol; 2016 Jan; 182():170-7. PubMed ID: 26711045
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs.
Lei JL; Xia SL; Wang Y; Du M; Xiang GT; Cong X; Luo Y; Li LF; Zhang L; Yu J; Hu Y; Qiu HJ; Sun Y
Immunol Lett; 2016 Jun; 174():63-71. PubMed ID: 27113530
[TBL] [Abstract][Full Text] [Related]
11. Construction and immunogenicity of a gE/gI/TK-deleted PRV based on porcine pseudorabies virus variant.
Zhao Y; Wang LQ; Zheng HH; Yang YR; Liu F; Zheng LL; Jin Y; Chen HY
Mol Cell Probes; 2020 Oct; 53():101605. PubMed ID: 32464159
[TBL] [Abstract][Full Text] [Related]
12. Pseudorabies virus (PRV) strain with defects in gE, gC, and TK genes protects piglets against an emerging PRV variant.
Lin J; Li Z; Feng Z; Fang Z; Chen J; Chen W; Liang W; Chen Q
J Vet Med Sci; 2020 Jun; 82(6):846-855. PubMed ID: 32336701
[TBL] [Abstract][Full Text] [Related]
13. Construction of a quadruple gene-deleted vaccine confers complete protective immunity against emerging PRV variant challenge in piglets.
Sun L; Tang Y; Yan K; Zhang H
Virol J; 2022 Jan; 19(1):19. PubMed ID: 35078501
[TBL] [Abstract][Full Text] [Related]
14. A live gI/gE-deleted pseudorabies virus (PRV) protects weaned piglets against lethal variant PRV challenge.
Yin Y; Xu Z; Liu X; Li P; Yang F; Zhao J; Fan Y; Sun X; Zhu L
Virus Genes; 2017 Aug; 53(4):565-572. PubMed ID: 28417300
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the Cap protein of porcine circovirus type 2d.
Xu RQ; Wang LQ; Zheng HH; Tian RB; Zheng LL; Ma SJ; Chen HY
Comp Immunol Microbiol Infect Dis; 2023 Oct; 101():102054. PubMed ID: 37651789
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms affecting the gE and gI proteins partly contribute to the virulence of a newly-emergent highly virulent Chinese pseudorabies virus.
Dong J; Gu Z; Jin L; Lv L; Wang J; Sun T; Bai J; Sun H; Wang X; Jiang P
Virology; 2018 Jun; 519():42-52. PubMed ID: 29631175
[TBL] [Abstract][Full Text] [Related]
17. An inactivated gE-deleted pseudorabies vaccine provides complete clinical protection and reduces virus shedding against challenge by a Chinese pseudorabies variant.
Wang J; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Gu Y; Liu C; Hou J
BMC Vet Res; 2016 Dec; 12(1):277. PubMed ID: 27923365
[TBL] [Abstract][Full Text] [Related]
18. Construction of a triple gene-deleted Chinese Pseudorabies virus variant and its efficacy study as a vaccine candidate on suckling piglets.
Zhang C; Guo L; Jia X; Wang T; Wang J; Sun Z; Wang L; Li X; Tan F; Tian K
Vaccine; 2015 May; 33(21):2432-7. PubMed ID: 25865469
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive evaluation of the safety and immunogenicity of a gene-deleted variant pseudorabies virus attenuated vaccine.
Li L; Du Y; Zhang Y; Li P; Liu X; Zhang X; Li J; Zhang T; Li X; Xiao D; Liu P; Qi P; Xiao J
Vet Res; 2022 Sep; 53(1):73. PubMed ID: 36138470
[TBL] [Abstract][Full Text] [Related]
20. Effective cross-protection of a lyophilized live gE/gI/TK-deleted pseudorabies virus (PRV) vaccine against classical and variant PRV challenges.
Sun Y; Zhao L; Fu ZF
Vet Microbiol; 2022 Apr; 267():109387. PubMed ID: 35276621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
